Deutsche Bank’s Regulus Therapeutics RGLS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-2,252
| Closed | -$3.94K | – | 3683 |
|
2025
Q1 | $3.94K | Buy |
+2,252
| New | +$3.94K | ﹤0.01% | 3488 |
|
2018
Q2 | – | Sell |
-1
| Closed | – | – | 4994 |
|
2018
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 4955 |
|
2017
Q4 | $0 | Sell |
1
-4,291
| -100% | – | ﹤0.01% | 4504 |
|
2017
Q3 | $643K | Buy |
4,292
+4,291
| +429,100% | +$643K | ﹤0.01% | 3226 |
|
2017
Q2 | $0 | Sell |
1
-437
| -100% | – | ﹤0.01% | 4542 |
|
2017
Q1 | $85K | Sell |
438
-1,378
| -76% | -$267K | ﹤0.01% | 3786 |
|
2016
Q4 | $489K | Sell |
1,816
-1,179
| -39% | -$317K | ﹤0.01% | 3103 |
|
2016
Q3 | $1.19M | Buy |
2,995
+2,127
| +245% | +$842K | ﹤0.01% | 2682 |
|
2016
Q2 | $299K | Buy |
868
+261
| +43% | +$89.9K | ﹤0.01% | 3456 |
|
2016
Q1 | $503K | Buy |
607
+24
| +4% | +$19.9K | ﹤0.01% | 3160 |
|
2015
Q4 | $608K | Sell |
583
-14
| -2% | -$14.6K | ﹤0.01% | 3111 |
|
2015
Q3 | $467K | Sell |
597
-572
| -49% | -$447K | ﹤0.01% | 3313 |
|
2015
Q2 | $1.54M | Buy |
1,169
+297
| +34% | +$390K | ﹤0.01% | 2647 |
|
2015
Q1 | $1.77M | Buy |
872
+352
| +68% | +$715K | ﹤0.01% | 2501 |
|
2014
Q4 | $999K | Buy |
520
+399
| +330% | +$767K | ﹤0.01% | 3149 |
|
2014
Q3 | $98K | Sell |
121
-17
| -12% | -$13.8K | ﹤0.01% | 4208 |
|
2014
Q2 | $132K | Sell |
138
-39
| -22% | -$37.3K | ﹤0.01% | 4177 |
|
2014
Q1 | $190K | Sell |
177
-6
| -3% | -$6.44K | ﹤0.01% | 3912 |
|
2013
Q4 | $162K | Buy |
183
+78
| +74% | +$69K | ﹤0.01% | 3788 |
|
2013
Q3 | $118K | Buy |
105
+23
| +28% | +$25.8K | ﹤0.01% | 4348 |
|
2013
Q2 | $95K | Buy |
+82
| New | +$95K | ﹤0.01% | 4232 |
|